Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
About Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases. Gilead's primary areas of focus include HIV/AIDS, liver disease, and serious cardiovascular and respiratory conditions.
Company Facts
- Headquarters
- Foster City
- Founded
- 1987
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_10001_max
- Funding Stage
- ipo
- Total Funding
- $4,413,500,000
- Last Funding Type
- post_ipo_debt
- Last Funding Date
- 2024-11-13
- Website
- gilead.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical
Social Links
Canonical: https://fsome.com/organization/gilead-sciences-29520 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.